Pretreatment of RML5-infected brain homogenate with CD21 led to decreased infection of and prion replication by highly susceptible N2a neuroblastoma cells compared to N2a cells infected with phosphate-buffered saline (PBS)-treated RML5 (Fig. 4). This evidence concerns the gene CR2 and neuroblastoma.